Using a serotype 4 AAV-RPE65 vector, Le Meur et al. also observed marked improvement in a subset of patients with comparable clinical characteristics, whereas patients with no nystagmus or worse visual acuity at baseline showed no alteration [40]. The gene discussed is RPE65; the disease is Nystagmus.